Mass tort intake: qualifying signal vs. noise

Mass tort campaigns don't fail because the ads don't work. They fail because intake can't absorb what the ads produce. A single campaign can drive five to twenty times normal call volume in a matter of days, and every one of those inbound contacts looks identical on paper: a name, a phone number, and interest in a case type. The entire economics of a mass tort docket rest on how well intake separates the claims that meet the criteria from the ones that don't.

The four-stage funnel

Every viable mass tort intake process moves through the same stages, and skipping any of them is how firms end up paying full price for cases they can never sign:

• Raw response — a form fill or inbound call with minimal information, usually just contact details and a checked interest box.
• Contact and initial screening — a basic eligibility filter confirming product exposure and approximate injury timing.
• Qualification — a deeper review against the specific case criteria matrix: exposure window, product or lot, diagnosis codes, treatment dates, and statute of limitations status.
• Retainer signing — the point where a qualified claimant actually becomes a client.

What "signal" actually looks like

A real signal on a mass tort lead isn't a checked box — it's documentation that maps to the specific case criteria for that tort: confirmed product or workplace exposure, diagnosis date and severity, treatment history, and an intake record showing the claimant was screened against a written qualification matrix before being marked qualified. Every active docket has its own version of this matrix, and firms that skip building one end up qualifying leads on gut feel, which is exactly how per-signed-case costs balloon.

Speed and language are qualification criteria too

Mass tort media spend has already paid for the click or the call — anything that causes that contact to go unqualified is money spent for nothing. A sub-20-second answer rate during active ad-spend windows is a common benchmark for firms serious about conversion. Language is the other frequently underestimated variable: on torts like Roundup, hair relaxer, talc, AFFF firefighter exposure, and Camp Lejeune, Spanish-dominant callers can represent 20 to 50 percent of inbound volume. English-only intake on those campaigns means turning away a meaningful share of the leads the ad spend already generated.

What actually separates viable leads by tort

Qualification criteria are tort-specific, but the categories repeat: exposure documentation (product, lot, manufacturer, or duration of use), diagnosis confirmation (date, code, severity), treatment history, statute-of-limitations status in the claimant's state, and a check for prior representation or retainer conflicts. Pricing on qualified and signed leads varies enormously by tort based on how narrow and evidentiary-heavy those criteria are — reported 2026 ranges run from roughly $2,200–2,700 for torts like Roundup and Paragard up to $4,000–6,000 for narrower-exposure cases like Paraquat.

What this means for lead buyers

• Ask every vendor for the written qualification matrix they use per tort — not a summary, the actual criteria.
• Audit consent documentation alongside case criteria; TCPA and state bar advertising rules both apply to mass tort intake.
• Measure response time, not just lead volume — a qualified lead that sits for hours converts like an unqualified one.
• Build or demand bilingual intake on any tort where Spanish-dominant callers make up a meaningful share of volume.

Sources